- Home
- TR vs XENE Comparison
TR vs XENE Comparison
Compare TR & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TR
- XENE
- Stock Information
- Founded
- TR 1896
- XENE 1996
- Country
- TR United States
- XENE Canada
- Employees
- TR N/A
- XENE N/A
- Industry
- TR Specialty Foods
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- TR Consumer Staples
- XENE Health Care
- Exchange
- TR Nasdaq
- XENE Nasdaq
- Market Cap
- TR 2.9B
- XENE 3.2B
- IPO Year
- TR N/A
- XENE 2014
- Fundamental
- Price
- TR $37.88
- XENE $41.94
- Analyst Decision
- TR
- XENE Strong Buy
- Analyst Count
- TR 0
- XENE 11
- Target Price
- TR N/A
- XENE $53.55
- AVG Volume (30 Days)
- TR 177.3K
- XENE 799.4K
- Earning Date
- TR 10-23-2025
- XENE 11-03-2025
- Dividend Yield
- TR 0.95%
- XENE N/A
- EPS Growth
- TR 0.79
- XENE N/A
- EPS
- TR 1.28
- XENE N/A
- Revenue
- TR $729,620,000.00
- XENE $7,500,000.00
- Revenue This Year
- TR N/A
- XENE N/A
- Revenue Next Year
- TR N/A
- XENE $207.88
- P/E Ratio
- TR $30.28
- XENE N/A
- Revenue Growth
- TR 0.34
- XENE N/A
- 52 Week Low
- TR $28.67
- XENE $26.74
- 52 Week High
- TR $44.27
- XENE $44.23
- Technical
- Relative Strength Index (RSI)
- TR 42.79
- XENE 60.17
- Support Level
- TR $38.39
- XENE $39.09
- Resistance Level
- TR $40.22
- XENE $42.31
- Average True Range (ATR)
- TR 1.07
- XENE 1.46
- MACD
- TR 0.17
- XENE 0.14
- Stochastic Oscillator
- TR 36.52
- XENE 92.61
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.